Diabetic pregnancy in rats leads to impaired glucose metabolism in offspring involving tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 expression

Life Sciences

Volumn 81, Issue 9, 2007, Pages 724-731

  Fujisawa, Yasuko ^a   Nakagawa, Yuichi ^a   Li, Ren Shan ^a   Liu, Yan Jun ^a   Ohzeki, Takehiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

11 Hydroxysteroid dehydrogenase type 1; Diabetic pregnancy; Glucocorticoid; Glucose metabolism; Obesity

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1; CORTICOSTERONE; GLUCOCORTICOID; MESSENGER RNA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; ENZYME ACTIVITY; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HORMONAL REGULATION; INSULIN RESISTANCE; LIVER; METABOLIC SYNDROME X; NEWBORN; NONHUMAN; OBESITY; PREGNANCY DIABETES MELLITUS; PROGENY; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; TISSUE SPECIFICITY;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CORTICOSTERONE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUCOSE; INSULIN RESISTANCE; LIVER; MALE; ORGAN SPECIFICITY; PREGNANCY; PREGNANCY IN DIABETICS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 34548050160     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.07.002     Document Type: Article

References (57)

1. Aerts C., and Van Asshe F.A. Rat fetal endocrine pancreas in experimental diabetes. Journal of Endocrinology 73 (1977) 339-346
2. Agarwal A.K. Cortisol metabolism and visceral obesity: role of 11β-hydroxysteroid dehydrogenase type 1 enzyme and reduced cofactor NADPH. Endocrine Research 29 (2003) 411-418
3. Andrews R.C., Herlihy O., Livingstone D.E.W., Andrew R., and Walker B.R. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 5587-5593
4. Atanasov A.G., Nashev L.G., Schweizer R.A.S., Frick C., and Odermatt A. Hexose-6-phosphate dehydrogenase determines the reaction direction of 11-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Letters 571 (2004) 129-133
5. Boloker J., Gertz S.J., and Simmons R.A. Gestational diabetes leads to their development of diabetes in adulthood in the rat. Diabetes 51 (2002) 1499-1509
6. Bujaska I.J., Walker E.A., Hewison M., and Stewart P.M. A switch in dehydrogenase to reductase activity of 11β-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stroma cells. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 1205-1210
7. Bujalska I.J., Draper N., Michailidou Z., Tomlinson J.W., White P.C., Chapman K.E., Walker E.A., and Stewart P.M. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysteroid dehydrogenase type 1. Journal of Molecular Endocrinology 34 (2005) 675-684
8. Catalano P.M., Thomas A., Huston-Presley L., and Amini S.B. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. American Journal of Obstetrics and Gynecology 189 (2003) 1698-1704
9. Cho N.H., Silverman B.L., Rizzo T.A., and Metzger B.E. Correlations between the intrauterine metabolic environment and blood pressure in adolescent offspring of diabetic mothers. Journal of Pediatrics 136 (1999) 587-592
10. Dabelea D., Hanson R.L., Lindsay R.S., Pettitt D.J., Imperatore G., Gabir M.M., Roumain J., Bennett P.H., and Knowler B.W. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity. Diabetes 49 (2000) 2208-2211
11. Draper N., Walker E.A., Bujalska I.J., Tomlinson J.W., Chalder S.M., Arlt W., Lavery G.G., Bedendo O., Ray D.W., Laing I., Malunowicz E., White P.C., Hewison M., Mason P.J., Connell J.M., Shackleton C.H., and Stewart P.M. Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nature Genetics 34 (2003) 434-439
12. Fujisawa Y., Nakagawa Y., Li R., and Ohzeki T. Streptozotocin-induced diabetes in the pregnant rat reduces 11β-hydroxysteroid dehydrogenase type 2 expression in placenta and fetal kidney. Life Sciences 75 (2004) 2797-2805
13. Grill V., Johansson B., Jalkanen P., and Eriksson U.J. Influence of severe diabetes mellitus early in pregnancy in the rat: effects on insulin sensitivity and insulin secretion in the offspring. Diabetologia 34 (1991) 373-378
14. Holemans K., Aerts L., and Van Assche F.A. Evidence for an insulin resistance in adult offspring of pregnant streptozotocin-diabetic rats. Diabetologia 34 (1991) 3481-3485
15. Holemans K., Gerber R.T., Meurrens K., De Clerck F., Poston L., and Van Assche F.A. Streptozotocin diabetes in the pregnant rat induces cardiovascular dysfunction in adult offspring. Diabetologia 42 (1999) 81-89
16. Jamieson P.M., Chapman K.E., Edwards C.R., and Seckl J.R. 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physiochemical and hormonal manipulations. Endocrinology 136 (1995) 4754-4761
17. Jamieson P.M., Walker B.R., Chapman K.E., Andrew R., Rossiter S., and Seckl J.R. 11β-Hydroxysteroid dehydrogenase type 1 is a predominant reductase in the intact perfused rat liver. Journal of Endocrinology 165 (2000) 685-692
18. Kervan A., Guillaume M., and Jost A. The endocrine pancreas of the fetus from diabetic pregnant rat. Diabetologia 15 (1978) 387-393
19. Lakshmi V., and Monder C. Purification and characterization of the corticosteroid 11β-dehydrogenase component of the rat liver 11β-hydroxysteroid dehydrogenase complex. Endocrinology 123 (1988) 2390-2398
20. Laplante M., Sell H., Macnaul K.L., Richard D., Berger J.P., and Deshaies Y. PPAR-γ activation mediates adipose deposit-specific effects on gene expression and lipoprotein lipase activity. Mechanism for modulation of postprandial lipemia and differential adipose accretion. Diabetes 52 (2003) 291-299
21. Lavery G.G., Walker E.A., Draper N., Jeyasuria P., Marcos J., Shackleton C.H., Parker K.L., White P.C., and Stewart P.M. Hexose-6-phosphate dehydrogenase knock-out mice lack 11β-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. Journal of Biological Chemistry 281 (2006) 6546-6551
22. Lindsay R.S., Wake D.J., Nair S., Bunt J., livingstone D.E., Permana P.A., tataranni P.A., and Walker B.R. Subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinaemia in Pima Indians and Caucasians. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 2738-2744
23. Liu Y.J., Nakagawa Y., Nasuda K., Saegusa H., and Igarashi Y. Effect of growth hormone, insulin and dexamethasone and 11β-hydroxysteroid dehydrogenase activity and gene expression on a primary culture of rat hepatocytes. Life Sciences 59 (1996) 227-234
24. Liu Y.J., Nakagawa Y., Toya K., and Ohzeki T. Sex-specific effects of growth hormone on hepatic 11β-hydroxysteroid dehydrogenase activity and gene expression in hypothyroid rats. Life Sciences 61 (1997) 325-334
25. Liu Y., Nakagawa Y., Wang Y., Li R., Li X., Ohzeki T., and Friedman T.C. Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice. Diabetes 52 (2003) 1409-1416
26. Livingstone D.E., Jones G.C., Smith K., Jamieson P.M., Andrew R., Kenyon C.J., and Walker B.R. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141 (2000) 560-563
27. Livingstone D.W.W., Jones G.C., Smith K., Jamieson P.M., Andrew R., Kenyon C.J., and Walker B.R. Understanding the role of glucocorticoid in obesity: tissue-specific alteration of corticosterone metabolism in obese Zucker rats. Endocrinology 141 (2000) 560-563
28. Malee M.P., and Wu K.Y. Adrenocortical imprint in the fetus of a diabetic gestation. Biology of the Neonate 76 (1999) 44-54
29. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., and Flier J.S. Transgenic model of visceral obesity and the metabolic syndrome. Science 294 (2001) 2166-2170
30. Morton N.M., Ramage L.E., and Seckl J.R. Down-regulation of adipose 11β-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease. Endocrinology 145 (2004) 2707-2712
31. Mziaut H., Korza G., Hand A., Gerard C., and Ozols J. Targeting proteins to the lumen of endoplasmic reticulum using N-terminal domains of 11-hydroxysteroid dehydrogenase and the 50-kDa esterase. Journal of Biological Chemistry 274 (1999) 14122-14129
32. Napolitano A., Voice M.W., Edwards C.R.W., Seckl J., and Chapman K.E. 11β-hydroxysteroid dehydrogenase 1 in adipocyte: expression is differentiation-dependent and hormonally regulated. Journal of Steroid Biochemistry and Molecular Biology 64 (1998) 251-260
33. Odermatt A., Arnold P., Stauffer A., Frey B.M., and Frey F.J. The N-terminal anchor sequences of 11-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. Journal of Biological Chemistry 274 (1999) 28762-28770
34. Ozols J. Isolation and the complete amino acid sequence of lumenal endoplasmic reticulum glucose-6-phosphate dehydrogenase. Proceeding of the National Academy of Sciences of the United States of America 90 (1993) 5302-5306
35. Ozols J. Lumenal orientation and post-translational modifications of liver microsomal 11-hydroxysteroid dehydrogenase. Journal of Biological Chemistry 270 (1995) 2305-2312
36. Paterson J.M., Morton N.M., Fievet C., Kenyon C.J., Holmes M.C., Staels B., Seckl J.R., and Mullins J.J. Metabolic syndrome without obesity: hepatic overexpression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proceeding of the National Academy of Sciences of the United States of America 101 (2004) 7088-7093
37. Paulmyer-Lacroix O., Boullu S., Oliver C., Alessi M.-C., and Grino M. Expression of the mRNA cording for 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 2701-2705
38. Pitkin R.M., and Van Orden D.E. Fetal effects of maternal streptozotocin diabetes. Endocrinology 94 (1974) 1247-1253
39. Pilkis S.J., and Granner D.K. Molecular physiology of the regulation of hepatic glucogenesis and glycolysis. Annual Review Physiology 54 (1992) 885-909
40. Raffaelli A., Saba A., Vignali E., Marcocci C., and Salvadori P. Direct determination of the ratio of tetrahydrocortisol + allo-tetrahydrocortisol to tetrahydrocortisone in urine by LC-MS-MS. Journal of Chromatography, B 830 (2006) 278-285
41. Rask E., Olsson T., Söderberg S., Andrew R., Livingstone D.E., Johnson O., and Walker B.R. Tissue-specific dysregulation of cortisol metabolism in human obesity. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 1418-1421
42. Rask E., Walker B.R., Söderberg S., Livingstone D.E., Eliasson M., Johnson O., Andrew R., and Olsson T. Tissue-specific changes in peripheral cortisol metabolism in obese woman: increased adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 3330-3336
43. Robinson J., Canavan J.P., Haj A.J.E., and Goldspink D.F. Maternal diabetes in rats I. Effects on placental growth and protein turnover. Diabetes 37 (1988) 1665-1670
44. Schwartz R., and Teramo K.A. Effects of diabetic pregnancy on the fetus and newborn. Seminars in Perinatology 24 (2000) 120-135
45. Seckl J.R., and Walker B.R. Minireview: 11β-hydroxysteroid dehydrogenase type 1-A tissue-specific amplifier of glucocorticoid action. Endocrinology 142 (2001) 1371-1376
46. Sobngwi E., Boudou P., Mauvais-Jarvis F., Leblanc H., Velho G., Vexiau P., Porcher R., Hadjadj S., Pratley R., Tataranni P.A., Calvo F., and Gautier J. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. The Lancet 361 (2003) 1861-1865
47. Stewart P.M., Boulton A., Kumar S., Clark P.M.S., and Shackleton C.H.L. Cortisol metabolism in human obesity: impaired cortisone-cortisol conversion in subjects with central obesity. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 1022-1027
48. Stulnig T.M., and Waldhäusl W. 11β-hydroxysteroid dehydrogenase type 1 in obesity and type 2 diabetes. Diabetologia 47 (2004) 1-11
49. Tannin G.M., Agarwal A.K., Monder C., New M.I., and White P.C. The human gene for 11β-hydroxysteroid dehydrogenase; structure, tissue distribution, and chromosomal localization. The Journal of Biological Chemistry 266 (1991) 16653-16658
50. Tenhola S., Turpeinen U., Halonen P., Hamalainen E., and Voutilainen R. Association of serum lipid concentrations, insulin resistance index and catch-up growth with serum cortisol/cortisone ratio by liquid chromatography tandem mass spectrometry in children born small for gestational age. Pediatric Research 58 (2005) 467-471
51. Thamotharan M., McKnight R.A., Thamotharan S., Kao D.J., and Devaskar S.U. Aberrant insulin-induced GLUT4 translocation predicts glucose intolerance in the offspring of a diabetic mother. American Journal of Physiology, Endocrinology and Metabolism 284 (2003) E901-E914
52. Tomlinson J.W., Sinha B., Bujalska I., Hewison M., and Stewart P.M. Expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 5630-5635
53. Tomlinson J.W., Walker E.A., Bujalska I.J., Draper N., Lavery G.G., Cooper M.S., Hewison M., and Stewart P.M. 11β-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Reviews 25 (2004) 831-866
54. Wake D.J., Rask E., Livingstone D.E.W., Söderberg S., Olsson T., and Walker B.R. Local and systemic impact of transcriptional up-regulation of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 3983-3988
55. Wake D.J., Homer N.Z.M., Andrew R., and Walker B.R. Acute in vivo regulation of 11β-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans. Journal of Clinical Endocrinology and Metabolism 91 (2006) 4682-4688
56. Weiss P.A.M., Tamussino K.F., Scholz H.S., Seissler J., Haas J., and Borkenstein M. Long-term follow-up of infants of mothers with type 1 diabetes. Diabetes Care 23 (2000) 905-911
57. Zar J.H. In: Zar J.H. (Ed). Biostatistical Analysis. 2nd ed. (1984), Prentice Hall, Englewood Cliffs, New jersey 150-160